Global Chronic Cough Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Chronic Cough Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Page: 103

Published Date: 09 Jan 2023

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Companies Mentioned
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

Chronic cough isdefined as a persistent cough that lasts long up to 6-8 weeks. It significantlyaffects the life of the patients by interrupting sleep, creating vomitingsensation, light-headedness, and even rib fractures. It is caused due tomultiple reasons such as infections, asthma, and gastro esophageal refluxdisease (GERD).

According to our (Global Info Research) latest study, the global Chronic Cough market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global Chronic Cough market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Chronic Cough market size and forecasts, in consumption value ($ Million), 2018-2029
Global Chronic Cough market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Chronic Cough market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Chronic Cough market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Chronic Cough
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Chronic Cough market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis AG, Teva Pharmaceutical Industries Ltd, GlaxoSmithKline, Bayer AG and Mylan N.V., etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation
Chronic Cough market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Oral
Injections
Nasal
Others

Market segment by Application
HospitalPharmacy
OnlinePharmacy
RetailPharmacy

Market segment by players, this report covers
Novartis AG
Teva Pharmaceutical Industries Ltd
GlaxoSmithKline
Bayer AG
Mylan N.V.
Amneal Pharmaceuticals, Inc.
Cipla Inc.
Reckitt Benckiser Group
Sun Pharmaceutical Industries Ltd
Aurobindo Pharma Ltd

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Chronic Cough product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Chronic Cough, with revenue, gross margin and global market share of Chronic Cough from 2018 to 2023.
Chapter 3, the Chronic Cough competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Chronic Cough market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Chronic Cough.
Chapter 13, to describe Chronic Cough research findings and conclusion.
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Chronic Cough
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Chronic Cough by Type
1.3.1 Overview: Global Chronic Cough Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Chronic Cough Consumption Value Market Share by Type in 2022
1.3.3 Oral
1.3.4 Injections
1.3.5 Nasal
1.3.6 Others
1.4 Global Chronic Cough Market by Application
1.4.1 Overview: Global Chronic Cough Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 HospitalPharmacy
1.4.3 OnlinePharmacy
1.4.4 RetailPharmacy
1.5 Global Chronic Cough Market Size & Forecast
1.6 Global Chronic Cough Market Size and Forecast by Region
1.6.1 Global Chronic Cough Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Chronic Cough Market Size by Region, (2018-2029)
1.6.3 North America Chronic Cough Market Size and Prospect (2018-2029)
1.6.4 Europe Chronic Cough Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Chronic Cough Market Size and Prospect (2018-2029)
1.6.6 South America Chronic Cough Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Chronic Cough Market Size and Prospect (2018-2029)

2 Company Profiles
2.1 Novartis AG
2.1.1 Novartis AG Details
2.1.2 Novartis AG Major Business
2.1.3 Novartis AG Chronic Cough Product and Solutions
2.1.4 Novartis AG Chronic Cough Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Novartis AG Recent Developments and Future Plans
2.2 Teva Pharmaceutical Industries Ltd
2.2.1 Teva Pharmaceutical Industries Ltd Details
2.2.2 Teva Pharmaceutical Industries Ltd Major Business
2.2.3 Teva Pharmaceutical Industries Ltd Chronic Cough Product and Solutions
2.2.4 Teva Pharmaceutical Industries Ltd Chronic Cough Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Teva Pharmaceutical Industries Ltd Recent Developments and Future Plans
2.3 GlaxoSmithKline
2.3.1 GlaxoSmithKline Details
2.3.2 GlaxoSmithKline Major Business
2.3.3 GlaxoSmithKline Chronic Cough Product and Solutions
2.3.4 GlaxoSmithKline Chronic Cough Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 GlaxoSmithKline Recent Developments and Future Plans
2.4 Bayer AG
2.4.1 Bayer AG Details
2.4.2 Bayer AG Major Business
2.4.3 Bayer AG Chronic Cough Product and Solutions
2.4.4 Bayer AG Chronic Cough Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Bayer AG Recent Developments and Future Plans
2.5 Mylan N.V.
2.5.1 Mylan N.V. Details
2.5.2 Mylan N.V. Major Business
2.5.3 Mylan N.V. Chronic Cough Product and Solutions
2.5.4 Mylan N.V. Chronic Cough Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Mylan N.V. Recent Developments and Future Plans
2.6 Amneal Pharmaceuticals, Inc.
2.6.1 Amneal Pharmaceuticals, Inc. Details
2.6.2 Amneal Pharmaceuticals, Inc. Major Business
2.6.3 Amneal Pharmaceuticals, Inc. Chronic Cough Product and Solutions
2.6.4 Amneal Pharmaceuticals, Inc. Chronic Cough Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Amneal Pharmaceuticals, Inc. Recent Developments and Future Plans
2.7 Cipla Inc.
2.7.1 Cipla Inc. Details
2.7.2 Cipla Inc. Major Business
2.7.3 Cipla Inc. Chronic Cough Product and Solutions
2.7.4 Cipla Inc. Chronic Cough Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Cipla Inc. Recent Developments and Future Plans
2.8 Reckitt Benckiser Group
2.8.1 Reckitt Benckiser Group Details
2.8.2 Reckitt Benckiser Group Major Business
2.8.3 Reckitt Benckiser Group Chronic Cough Product and Solutions
2.8.4 Reckitt Benckiser Group Chronic Cough Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Reckitt Benckiser Group Recent Developments and Future Plans
2.9 Sun Pharmaceutical Industries Ltd
2.9.1 Sun Pharmaceutical Industries Ltd Details
2.9.2 Sun Pharmaceutical Industries Ltd Major Business
2.9.3 Sun Pharmaceutical Industries Ltd Chronic Cough Product and Solutions
2.9.4 Sun Pharmaceutical Industries Ltd Chronic Cough Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Sun Pharmaceutical Industries Ltd Recent Developments and Future Plans
2.10 Aurobindo Pharma Ltd
2.10.1 Aurobindo Pharma Ltd Details
2.10.2 Aurobindo Pharma Ltd Major Business
2.10.3 Aurobindo Pharma Ltd Chronic Cough Product and Solutions
2.10.4 Aurobindo Pharma Ltd Chronic Cough Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Aurobindo Pharma Ltd Recent Developments and Future Plans

3 Market Competition, by Players
3.1 Global Chronic Cough Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Chronic Cough by Company Revenue
3.2.2 Top 3 Chronic Cough Players Market Share in 2022
3.2.3 Top 6 Chronic Cough Players Market Share in 2022
3.3 Chronic Cough Market: Overall Company Footprint Analysis
3.3.1 Chronic Cough Market: Region Footprint
3.3.2 Chronic Cough Market: Company Product Type Footprint
3.3.3 Chronic Cough Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
4.1 Global Chronic Cough Consumption Value and Market Share by Type (2018-2023)
4.2 Global Chronic Cough Market Forecast by Type (2024-2029)

5 Market Size Segment by Application
5.1 Global Chronic Cough Consumption Value Market Share by Application (2018-2023)
5.2 Global Chronic Cough Market Forecast by Application (2024-2029)

6 North America
6.1 North America Chronic Cough Consumption Value by Type (2018-2029)
6.2 North America Chronic Cough Consumption Value by Application (2018-2029)
6.3 North America Chronic Cough Market Size by Country
6.3.1 North America Chronic Cough Consumption Value by Country (2018-2029)
6.3.2 United States Chronic Cough Market Size and Forecast (2018-2029)
6.3.3 Canada Chronic Cough Market Size and Forecast (2018-2029)
6.3.4 Mexico Chronic Cough Market Size and Forecast (2018-2029)

7 Europe
7.1 Europe Chronic Cough Consumption Value by Type (2018-2029)
7.2 Europe Chronic Cough Consumption Value by Application (2018-2029)
7.3 Europe Chronic Cough Market Size by Country
7.3.1 Europe Chronic Cough Consumption Value by Country (2018-2029)
7.3.2 Germany Chronic Cough Market Size and Forecast (2018-2029)
7.3.3 France Chronic Cough Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Chronic Cough Market Size and Forecast (2018-2029)
7.3.5 Russia Chronic Cough Market Size and Forecast (2018-2029)
7.3.6 Italy Chronic Cough Market Size and Forecast (2018-2029)

8 Asia-Pacific
8.1 Asia-Pacific Chronic Cough Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Chronic Cough Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Chronic Cough Market Size by Region
8.3.1 Asia-Pacific Chronic Cough Consumption Value by Region (2018-2029)
8.3.2 China Chronic Cough Market Size and Forecast (2018-2029)
8.3.3 Japan Chronic Cough Market Size and Forecast (2018-2029)
8.3.4 South Korea Chronic Cough Market Size and Forecast (2018-2029)
8.3.5 India Chronic Cough Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Chronic Cough Market Size and Forecast (2018-2029)
8.3.7 Australia Chronic Cough Market Size and Forecast (2018-2029)

9 South America
9.1 South America Chronic Cough Consumption Value by Type (2018-2029)
9.2 South America Chronic Cough Consumption Value by Application (2018-2029)
9.3 South America Chronic Cough Market Size by Country
9.3.1 South America Chronic Cough Consumption Value by Country (2018-2029)
9.3.2 Brazil Chronic Cough Market Size and Forecast (2018-2029)
9.3.3 Argentina Chronic Cough Market Size and Forecast (2018-2029)

10 Middle East & Africa
10.1 Middle East & Africa Chronic Cough Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Chronic Cough Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Chronic Cough Market Size by Country
10.3.1 Middle East & Africa Chronic Cough Consumption Value by Country (2018-2029)
10.3.2 Turkey Chronic Cough Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Chronic Cough Market Size and Forecast (2018-2029)
10.3.4 UAE Chronic Cough Market Size and Forecast (2018-2029)

11 Market Dynamics
11.1 Chronic Cough Market Drivers
11.2 Chronic Cough Market Restraints
11.3 Chronic Cough Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis
12.1 Chronic Cough Industry Chain
12.2 Chronic Cough Upstream Analysis
12.3 Chronic Cough Midstream Analysis
12.4 Chronic Cough Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Chronic Cough Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Chronic Cough Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Chronic Cough Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Chronic Cough Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Novartis AG Company Information, Head Office, and Major Competitors
Table 6. Novartis AG Major Business
Table 7. Novartis AG Chronic Cough Product and Solutions
Table 8. Novartis AG Chronic Cough Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Novartis AG Recent Developments and Future Plans
Table 10. Teva Pharmaceutical Industries Ltd Company Information, Head Office, and Major Competitors
Table 11. Teva Pharmaceutical Industries Ltd Major Business
Table 12. Teva Pharmaceutical Industries Ltd Chronic Cough Product and Solutions
Table 13. Teva Pharmaceutical Industries Ltd Chronic Cough Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Teva Pharmaceutical Industries Ltd Recent Developments and Future Plans
Table 15. GlaxoSmithKline Company Information, Head Office, and Major Competitors
Table 16. GlaxoSmithKline Major Business
Table 17. GlaxoSmithKline Chronic Cough Product and Solutions
Table 18. GlaxoSmithKline Chronic Cough Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. GlaxoSmithKline Recent Developments and Future Plans
Table 20. Bayer AG Company Information, Head Office, and Major Competitors
Table 21. Bayer AG Major Business
Table 22. Bayer AG Chronic Cough Product and Solutions
Table 23. Bayer AG Chronic Cough Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Bayer AG Recent Developments and Future Plans
Table 25. Mylan N.V. Company Information, Head Office, and Major Competitors
Table 26. Mylan N.V. Major Business
Table 27. Mylan N.V. Chronic Cough Product and Solutions
Table 28. Mylan N.V. Chronic Cough Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Mylan N.V. Recent Developments and Future Plans
Table 30. Amneal Pharmaceuticals, Inc. Company Information, Head Office, and Major Competitors
Table 31. Amneal Pharmaceuticals, Inc. Major Business
Table 32. Amneal Pharmaceuticals, Inc. Chronic Cough Product and Solutions
Table 33. Amneal Pharmaceuticals, Inc. Chronic Cough Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Amneal Pharmaceuticals, Inc. Recent Developments and Future Plans
Table 35. Cipla Inc. Company Information, Head Office, and Major Competitors
Table 36. Cipla Inc. Major Business
Table 37. Cipla Inc. Chronic Cough Product and Solutions
Table 38. Cipla Inc. Chronic Cough Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Cipla Inc. Recent Developments and Future Plans
Table 40. Reckitt Benckiser Group Company Information, Head Office, and Major Competitors
Table 41. Reckitt Benckiser Group Major Business
Table 42. Reckitt Benckiser Group Chronic Cough Product and Solutions
Table 43. Reckitt Benckiser Group Chronic Cough Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Reckitt Benckiser Group Recent Developments and Future Plans
Table 45. Sun Pharmaceutical Industries Ltd Company Information, Head Office, and Major Competitors
Table 46. Sun Pharmaceutical Industries Ltd Major Business
Table 47. Sun Pharmaceutical Industries Ltd Chronic Cough Product and Solutions
Table 48. Sun Pharmaceutical Industries Ltd Chronic Cough Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Sun Pharmaceutical Industries Ltd Recent Developments and Future Plans
Table 50. Aurobindo Pharma Ltd Company Information, Head Office, and Major Competitors
Table 51. Aurobindo Pharma Ltd Major Business
Table 52. Aurobindo Pharma Ltd Chronic Cough Product and Solutions
Table 53. Aurobindo Pharma Ltd Chronic Cough Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Aurobindo Pharma Ltd Recent Developments and Future Plans
Table 55. Global Chronic Cough Revenue (USD Million) by Players (2018-2023)
Table 56. Global Chronic Cough Revenue Share by Players (2018-2023)
Table 57. Breakdown of Chronic Cough by Company Type (Tier 1, Tier 2, and Tier 3)
Table 58. Market Position of Players in Chronic Cough, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 59. Head Office of Key Chronic Cough Players
Table 60. Chronic Cough Market: Company Product Type Footprint
Table 61. Chronic Cough Market: Company Product Application Footprint
Table 62. Chronic Cough New Market Entrants and Barriers to Market Entry
Table 63. Chronic Cough Mergers, Acquisition, Agreements, and Collaborations
Table 64. Global Chronic Cough Consumption Value (USD Million) by Type (2018-2023)
Table 65. Global Chronic Cough Consumption Value Share by Type (2018-2023)
Table 66. Global Chronic Cough Consumption Value Forecast by Type (2024-2029)
Table 67. Global Chronic Cough Consumption Value by Application (2018-2023)
Table 68. Global Chronic Cough Consumption Value Forecast by Application (2024-2029)
Table 69. North America Chronic Cough Consumption Value by Type (2018-2023) & (USD Million)
Table 70. North America Chronic Cough Consumption Value by Type (2024-2029) & (USD Million)
Table 71. North America Chronic Cough Consumption Value by Application (2018-2023) & (USD Million)
Table 72. North America Chronic Cough Consumption Value by Application (2024-2029) & (USD Million)
Table 73. North America Chronic Cough Consumption Value by Country (2018-2023) & (USD Million)
Table 74. North America Chronic Cough Consumption Value by Country (2024-2029) & (USD Million)
Table 75. Europe Chronic Cough Consumption Value by Type (2018-2023) & (USD Million)
Table 76. Europe Chronic Cough Consumption Value by Type (2024-2029) & (USD Million)
Table 77. Europe Chronic Cough Consumption Value by Application (2018-2023) & (USD Million)
Table 78. Europe Chronic Cough Consumption Value by Application (2024-2029) & (USD Million)
Table 79. Europe Chronic Cough Consumption Value by Country (2018-2023) & (USD Million)
Table 80. Europe Chronic Cough Consumption Value by Country (2024-2029) & (USD Million)
Table 81. Asia-Pacific Chronic Cough Consumption Value by Type (2018-2023) & (USD Million)
Table 82. Asia-Pacific Chronic Cough Consumption Value by Type (2024-2029) & (USD Million)
Table 83. Asia-Pacific Chronic Cough Consumption Value by Application (2018-2023) & (USD Million)
Table 84. Asia-Pacific Chronic Cough Consumption Value by Application (2024-2029) & (USD Million)
Table 85. Asia-Pacific Chronic Cough Consumption Value by Region (2018-2023) & (USD Million)
Table 86. Asia-Pacific Chronic Cough Consumption Value by Region (2024-2029) & (USD Million)
Table 87. South America Chronic Cough Consumption Value by Type (2018-2023) & (USD Million)
Table 88. South America Chronic Cough Consumption Value by Type (2024-2029) & (USD Million)
Table 89. South America Chronic Cough Consumption Value by Application (2018-2023) & (USD Million)
Table 90. South America Chronic Cough Consumption Value by Application (2024-2029) & (USD Million)
Table 91. South America Chronic Cough Consumption Value by Country (2018-2023) & (USD Million)
Table 92. South America Chronic Cough Consumption Value by Country (2024-2029) & (USD Million)
Table 93. Middle East & Africa Chronic Cough Consumption Value by Type (2018-2023) & (USD Million)
Table 94. Middle East & Africa Chronic Cough Consumption Value by Type (2024-2029) & (USD Million)
Table 95. Middle East & Africa Chronic Cough Consumption Value by Application (2018-2023) & (USD Million)
Table 96. Middle East & Africa Chronic Cough Consumption Value by Application (2024-2029) & (USD Million)
Table 97. Middle East & Africa Chronic Cough Consumption Value by Country (2018-2023) & (USD Million)
Table 98. Middle East & Africa Chronic Cough Consumption Value by Country (2024-2029) & (USD Million)
Table 99. Chronic Cough Raw Material
Table 100. Key Suppliers of Chronic Cough Raw Materials
List of Figures
Figure 1. Chronic Cough Picture
Figure 2. Global Chronic Cough Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Chronic Cough Consumption Value Market Share by Type in 2022
Figure 4. Oral
Figure 5. Injections
Figure 6. Nasal
Figure 7. Others
Figure 8. Global Chronic Cough Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 9. Chronic Cough Consumption Value Market Share by Application in 2022
Figure 10. HospitalPharmacy Picture
Figure 11. OnlinePharmacy Picture
Figure 12. RetailPharmacy Picture
Figure 13. Global Chronic Cough Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global Chronic Cough Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Market Chronic Cough Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 16. Global Chronic Cough Consumption Value Market Share by Region (2018-2029)
Figure 17. Global Chronic Cough Consumption Value Market Share by Region in 2022
Figure 18. North America Chronic Cough Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Chronic Cough Consumption Value (2018-2029) & (USD Million)
Figure 20. Asia-Pacific Chronic Cough Consumption Value (2018-2029) & (USD Million)
Figure 21. South America Chronic Cough Consumption Value (2018-2029) & (USD Million)
Figure 22. Middle East and Africa Chronic Cough Consumption Value (2018-2029) & (USD Million)
Figure 23. Global Chronic Cough Revenue Share by Players in 2022
Figure 24. Chronic Cough Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 25. Global Top 3 Players Chronic Cough Market Share in 2022
Figure 26. Global Top 6 Players Chronic Cough Market Share in 2022
Figure 27. Global Chronic Cough Consumption Value Share by Type (2018-2023)
Figure 28. Global Chronic Cough Market Share Forecast by Type (2024-2029)
Figure 29. Global Chronic Cough Consumption Value Share by Application (2018-2023)
Figure 30. Global Chronic Cough Market Share Forecast by Application (2024-2029)
Figure 31. North America Chronic Cough Consumption Value Market Share by Type (2018-2029)
Figure 32. North America Chronic Cough Consumption Value Market Share by Application (2018-2029)
Figure 33. North America Chronic Cough Consumption Value Market Share by Country (2018-2029)
Figure 34. United States Chronic Cough Consumption Value (2018-2029) & (USD Million)
Figure 35. Canada Chronic Cough Consumption Value (2018-2029) & (USD Million)
Figure 36. Mexico Chronic Cough Consumption Value (2018-2029) & (USD Million)
Figure 37. Europe Chronic Cough Consumption Value Market Share by Type (2018-2029)
Figure 38. Europe Chronic Cough Consumption Value Market Share by Application (2018-2029)
Figure 39. Europe Chronic Cough Consumption Value Market Share by Country (2018-2029)
Figure 40. Germany Chronic Cough Consumption Value (2018-2029) & (USD Million)
Figure 41. France Chronic Cough Consumption Value (2018-2029) & (USD Million)
Figure 42. United Kingdom Chronic Cough Consumption Value (2018-2029) & (USD Million)
Figure 43. Russia Chronic Cough Consumption Value (2018-2029) & (USD Million)
Figure 44. Italy Chronic Cough Consumption Value (2018-2029) & (USD Million)
Figure 45. Asia-Pacific Chronic Cough Consumption Value Market Share by Type (2018-2029)
Figure 46. Asia-Pacific Chronic Cough Consumption Value Market Share by Application (2018-2029)
Figure 47. Asia-Pacific Chronic Cough Consumption Value Market Share by Region (2018-2029)
Figure 48. China Chronic Cough Consumption Value (2018-2029) & (USD Million)
Figure 49. Japan Chronic Cough Consumption Value (2018-2029) & (USD Million)
Figure 50. South Korea Chronic Cough Consumption Value (2018-2029) & (USD Million)
Figure 51. India Chronic Cough Consumption Value (2018-2029) & (USD Million)
Figure 52. Southeast Asia Chronic Cough Consumption Value (2018-2029) & (USD Million)
Figure 53. Australia Chronic Cough Consumption Value (2018-2029) & (USD Million)
Figure 54. South America Chronic Cough Consumption Value Market Share by Type (2018-2029)
Figure 55. South America Chronic Cough Consumption Value Market Share by Application (2018-2029)
Figure 56. South America Chronic Cough Consumption Value Market Share by Country (2018-2029)
Figure 57. Brazil Chronic Cough Consumption Value (2018-2029) & (USD Million)
Figure 58. Argentina Chronic Cough Consumption Value (2018-2029) & (USD Million)
Figure 59. Middle East and Africa Chronic Cough Consumption Value Market Share by Type (2018-2029)
Figure 60. Middle East and Africa Chronic Cough Consumption Value Market Share by Application (2018-2029)
Figure 61. Middle East and Africa Chronic Cough Consumption Value Market Share by Country (2018-2029)
Figure 62. Turkey Chronic Cough Consumption Value (2018-2029) & (USD Million)
Figure 63. Saudi Arabia Chronic Cough Consumption Value (2018-2029) & (USD Million)
Figure 64. UAE Chronic Cough Consumption Value (2018-2029) & (USD Million)
Figure 65. Chronic Cough Market Drivers
Figure 66. Chronic Cough Market Restraints
Figure 67. Chronic Cough Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Manufacturing Cost Structure Analysis of Chronic Cough in 2022
Figure 70. Manufacturing Process Analysis of Chronic Cough
Figure 71. Chronic Cough Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Novartis AG
Teva Pharmaceutical Industries Ltd
GlaxoSmithKline
Bayer AG
Mylan N.V.
Amneal Pharmaceuticals, Inc.
Cipla Inc.
Reckitt Benckiser Group
Sun Pharmaceutical Industries Ltd
Aurobindo Pharma Ltd
shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Chronic Cough Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Chronic Cough Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Page: 103

Published Date: 09 Jan 2023

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

Chronic cough isdefined as a persistent cough that lasts long up to 6-8 weeks. It significantlyaffects the life of the patients by interrupting sleep, creating vomitingsensation, light-headedness, and even rib fractures. It is caused due tomultiple reasons such as infections, asthma, and gastro esophageal refluxdisease (GERD).

According to our (Global Info Research) latest study, the global Chronic Cough market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global Chronic Cough market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Chronic Cough market size and forecasts, in consumption value ($ Million), 2018-2029
Global Chronic Cough market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Chronic Cough market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Chronic Cough market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Chronic Cough
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Chronic Cough market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis AG, Teva Pharmaceutical Industries Ltd, GlaxoSmithKline, Bayer AG and Mylan N.V., etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation
Chronic Cough market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Oral
Injections
Nasal
Others

Market segment by Application
HospitalPharmacy
OnlinePharmacy
RetailPharmacy

Market segment by players, this report covers
Novartis AG
Teva Pharmaceutical Industries Ltd
GlaxoSmithKline
Bayer AG
Mylan N.V.
Amneal Pharmaceuticals, Inc.
Cipla Inc.
Reckitt Benckiser Group
Sun Pharmaceutical Industries Ltd
Aurobindo Pharma Ltd

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Chronic Cough product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Chronic Cough, with revenue, gross margin and global market share of Chronic Cough from 2018 to 2023.
Chapter 3, the Chronic Cough competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Chronic Cough market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Chronic Cough.
Chapter 13, to describe Chronic Cough research findings and conclusion.
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Chronic Cough
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Chronic Cough by Type
1.3.1 Overview: Global Chronic Cough Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Chronic Cough Consumption Value Market Share by Type in 2022
1.3.3 Oral
1.3.4 Injections
1.3.5 Nasal
1.3.6 Others
1.4 Global Chronic Cough Market by Application
1.4.1 Overview: Global Chronic Cough Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 HospitalPharmacy
1.4.3 OnlinePharmacy
1.4.4 RetailPharmacy
1.5 Global Chronic Cough Market Size & Forecast
1.6 Global Chronic Cough Market Size and Forecast by Region
1.6.1 Global Chronic Cough Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Chronic Cough Market Size by Region, (2018-2029)
1.6.3 North America Chronic Cough Market Size and Prospect (2018-2029)
1.6.4 Europe Chronic Cough Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Chronic Cough Market Size and Prospect (2018-2029)
1.6.6 South America Chronic Cough Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Chronic Cough Market Size and Prospect (2018-2029)

2 Company Profiles
2.1 Novartis AG
2.1.1 Novartis AG Details
2.1.2 Novartis AG Major Business
2.1.3 Novartis AG Chronic Cough Product and Solutions
2.1.4 Novartis AG Chronic Cough Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Novartis AG Recent Developments and Future Plans
2.2 Teva Pharmaceutical Industries Ltd
2.2.1 Teva Pharmaceutical Industries Ltd Details
2.2.2 Teva Pharmaceutical Industries Ltd Major Business
2.2.3 Teva Pharmaceutical Industries Ltd Chronic Cough Product and Solutions
2.2.4 Teva Pharmaceutical Industries Ltd Chronic Cough Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Teva Pharmaceutical Industries Ltd Recent Developments and Future Plans
2.3 GlaxoSmithKline
2.3.1 GlaxoSmithKline Details
2.3.2 GlaxoSmithKline Major Business
2.3.3 GlaxoSmithKline Chronic Cough Product and Solutions
2.3.4 GlaxoSmithKline Chronic Cough Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 GlaxoSmithKline Recent Developments and Future Plans
2.4 Bayer AG
2.4.1 Bayer AG Details
2.4.2 Bayer AG Major Business
2.4.3 Bayer AG Chronic Cough Product and Solutions
2.4.4 Bayer AG Chronic Cough Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Bayer AG Recent Developments and Future Plans
2.5 Mylan N.V.
2.5.1 Mylan N.V. Details
2.5.2 Mylan N.V. Major Business
2.5.3 Mylan N.V. Chronic Cough Product and Solutions
2.5.4 Mylan N.V. Chronic Cough Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Mylan N.V. Recent Developments and Future Plans
2.6 Amneal Pharmaceuticals, Inc.
2.6.1 Amneal Pharmaceuticals, Inc. Details
2.6.2 Amneal Pharmaceuticals, Inc. Major Business
2.6.3 Amneal Pharmaceuticals, Inc. Chronic Cough Product and Solutions
2.6.4 Amneal Pharmaceuticals, Inc. Chronic Cough Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Amneal Pharmaceuticals, Inc. Recent Developments and Future Plans
2.7 Cipla Inc.
2.7.1 Cipla Inc. Details
2.7.2 Cipla Inc. Major Business
2.7.3 Cipla Inc. Chronic Cough Product and Solutions
2.7.4 Cipla Inc. Chronic Cough Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Cipla Inc. Recent Developments and Future Plans
2.8 Reckitt Benckiser Group
2.8.1 Reckitt Benckiser Group Details
2.8.2 Reckitt Benckiser Group Major Business
2.8.3 Reckitt Benckiser Group Chronic Cough Product and Solutions
2.8.4 Reckitt Benckiser Group Chronic Cough Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Reckitt Benckiser Group Recent Developments and Future Plans
2.9 Sun Pharmaceutical Industries Ltd
2.9.1 Sun Pharmaceutical Industries Ltd Details
2.9.2 Sun Pharmaceutical Industries Ltd Major Business
2.9.3 Sun Pharmaceutical Industries Ltd Chronic Cough Product and Solutions
2.9.4 Sun Pharmaceutical Industries Ltd Chronic Cough Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Sun Pharmaceutical Industries Ltd Recent Developments and Future Plans
2.10 Aurobindo Pharma Ltd
2.10.1 Aurobindo Pharma Ltd Details
2.10.2 Aurobindo Pharma Ltd Major Business
2.10.3 Aurobindo Pharma Ltd Chronic Cough Product and Solutions
2.10.4 Aurobindo Pharma Ltd Chronic Cough Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Aurobindo Pharma Ltd Recent Developments and Future Plans

3 Market Competition, by Players
3.1 Global Chronic Cough Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Chronic Cough by Company Revenue
3.2.2 Top 3 Chronic Cough Players Market Share in 2022
3.2.3 Top 6 Chronic Cough Players Market Share in 2022
3.3 Chronic Cough Market: Overall Company Footprint Analysis
3.3.1 Chronic Cough Market: Region Footprint
3.3.2 Chronic Cough Market: Company Product Type Footprint
3.3.3 Chronic Cough Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
4.1 Global Chronic Cough Consumption Value and Market Share by Type (2018-2023)
4.2 Global Chronic Cough Market Forecast by Type (2024-2029)

5 Market Size Segment by Application
5.1 Global Chronic Cough Consumption Value Market Share by Application (2018-2023)
5.2 Global Chronic Cough Market Forecast by Application (2024-2029)

6 North America
6.1 North America Chronic Cough Consumption Value by Type (2018-2029)
6.2 North America Chronic Cough Consumption Value by Application (2018-2029)
6.3 North America Chronic Cough Market Size by Country
6.3.1 North America Chronic Cough Consumption Value by Country (2018-2029)
6.3.2 United States Chronic Cough Market Size and Forecast (2018-2029)
6.3.3 Canada Chronic Cough Market Size and Forecast (2018-2029)
6.3.4 Mexico Chronic Cough Market Size and Forecast (2018-2029)

7 Europe
7.1 Europe Chronic Cough Consumption Value by Type (2018-2029)
7.2 Europe Chronic Cough Consumption Value by Application (2018-2029)
7.3 Europe Chronic Cough Market Size by Country
7.3.1 Europe Chronic Cough Consumption Value by Country (2018-2029)
7.3.2 Germany Chronic Cough Market Size and Forecast (2018-2029)
7.3.3 France Chronic Cough Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Chronic Cough Market Size and Forecast (2018-2029)
7.3.5 Russia Chronic Cough Market Size and Forecast (2018-2029)
7.3.6 Italy Chronic Cough Market Size and Forecast (2018-2029)

8 Asia-Pacific
8.1 Asia-Pacific Chronic Cough Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Chronic Cough Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Chronic Cough Market Size by Region
8.3.1 Asia-Pacific Chronic Cough Consumption Value by Region (2018-2029)
8.3.2 China Chronic Cough Market Size and Forecast (2018-2029)
8.3.3 Japan Chronic Cough Market Size and Forecast (2018-2029)
8.3.4 South Korea Chronic Cough Market Size and Forecast (2018-2029)
8.3.5 India Chronic Cough Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Chronic Cough Market Size and Forecast (2018-2029)
8.3.7 Australia Chronic Cough Market Size and Forecast (2018-2029)

9 South America
9.1 South America Chronic Cough Consumption Value by Type (2018-2029)
9.2 South America Chronic Cough Consumption Value by Application (2018-2029)
9.3 South America Chronic Cough Market Size by Country
9.3.1 South America Chronic Cough Consumption Value by Country (2018-2029)
9.3.2 Brazil Chronic Cough Market Size and Forecast (2018-2029)
9.3.3 Argentina Chronic Cough Market Size and Forecast (2018-2029)

10 Middle East & Africa
10.1 Middle East & Africa Chronic Cough Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Chronic Cough Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Chronic Cough Market Size by Country
10.3.1 Middle East & Africa Chronic Cough Consumption Value by Country (2018-2029)
10.3.2 Turkey Chronic Cough Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Chronic Cough Market Size and Forecast (2018-2029)
10.3.4 UAE Chronic Cough Market Size and Forecast (2018-2029)

11 Market Dynamics
11.1 Chronic Cough Market Drivers
11.2 Chronic Cough Market Restraints
11.3 Chronic Cough Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis
12.1 Chronic Cough Industry Chain
12.2 Chronic Cough Upstream Analysis
12.3 Chronic Cough Midstream Analysis
12.4 Chronic Cough Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Chronic Cough Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Chronic Cough Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Chronic Cough Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Chronic Cough Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Novartis AG Company Information, Head Office, and Major Competitors
Table 6. Novartis AG Major Business
Table 7. Novartis AG Chronic Cough Product and Solutions
Table 8. Novartis AG Chronic Cough Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Novartis AG Recent Developments and Future Plans
Table 10. Teva Pharmaceutical Industries Ltd Company Information, Head Office, and Major Competitors
Table 11. Teva Pharmaceutical Industries Ltd Major Business
Table 12. Teva Pharmaceutical Industries Ltd Chronic Cough Product and Solutions
Table 13. Teva Pharmaceutical Industries Ltd Chronic Cough Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Teva Pharmaceutical Industries Ltd Recent Developments and Future Plans
Table 15. GlaxoSmithKline Company Information, Head Office, and Major Competitors
Table 16. GlaxoSmithKline Major Business
Table 17. GlaxoSmithKline Chronic Cough Product and Solutions
Table 18. GlaxoSmithKline Chronic Cough Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. GlaxoSmithKline Recent Developments and Future Plans
Table 20. Bayer AG Company Information, Head Office, and Major Competitors
Table 21. Bayer AG Major Business
Table 22. Bayer AG Chronic Cough Product and Solutions
Table 23. Bayer AG Chronic Cough Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Bayer AG Recent Developments and Future Plans
Table 25. Mylan N.V. Company Information, Head Office, and Major Competitors
Table 26. Mylan N.V. Major Business
Table 27. Mylan N.V. Chronic Cough Product and Solutions
Table 28. Mylan N.V. Chronic Cough Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Mylan N.V. Recent Developments and Future Plans
Table 30. Amneal Pharmaceuticals, Inc. Company Information, Head Office, and Major Competitors
Table 31. Amneal Pharmaceuticals, Inc. Major Business
Table 32. Amneal Pharmaceuticals, Inc. Chronic Cough Product and Solutions
Table 33. Amneal Pharmaceuticals, Inc. Chronic Cough Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Amneal Pharmaceuticals, Inc. Recent Developments and Future Plans
Table 35. Cipla Inc. Company Information, Head Office, and Major Competitors
Table 36. Cipla Inc. Major Business
Table 37. Cipla Inc. Chronic Cough Product and Solutions
Table 38. Cipla Inc. Chronic Cough Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Cipla Inc. Recent Developments and Future Plans
Table 40. Reckitt Benckiser Group Company Information, Head Office, and Major Competitors
Table 41. Reckitt Benckiser Group Major Business
Table 42. Reckitt Benckiser Group Chronic Cough Product and Solutions
Table 43. Reckitt Benckiser Group Chronic Cough Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Reckitt Benckiser Group Recent Developments and Future Plans
Table 45. Sun Pharmaceutical Industries Ltd Company Information, Head Office, and Major Competitors
Table 46. Sun Pharmaceutical Industries Ltd Major Business
Table 47. Sun Pharmaceutical Industries Ltd Chronic Cough Product and Solutions
Table 48. Sun Pharmaceutical Industries Ltd Chronic Cough Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Sun Pharmaceutical Industries Ltd Recent Developments and Future Plans
Table 50. Aurobindo Pharma Ltd Company Information, Head Office, and Major Competitors
Table 51. Aurobindo Pharma Ltd Major Business
Table 52. Aurobindo Pharma Ltd Chronic Cough Product and Solutions
Table 53. Aurobindo Pharma Ltd Chronic Cough Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Aurobindo Pharma Ltd Recent Developments and Future Plans
Table 55. Global Chronic Cough Revenue (USD Million) by Players (2018-2023)
Table 56. Global Chronic Cough Revenue Share by Players (2018-2023)
Table 57. Breakdown of Chronic Cough by Company Type (Tier 1, Tier 2, and Tier 3)
Table 58. Market Position of Players in Chronic Cough, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 59. Head Office of Key Chronic Cough Players
Table 60. Chronic Cough Market: Company Product Type Footprint
Table 61. Chronic Cough Market: Company Product Application Footprint
Table 62. Chronic Cough New Market Entrants and Barriers to Market Entry
Table 63. Chronic Cough Mergers, Acquisition, Agreements, and Collaborations
Table 64. Global Chronic Cough Consumption Value (USD Million) by Type (2018-2023)
Table 65. Global Chronic Cough Consumption Value Share by Type (2018-2023)
Table 66. Global Chronic Cough Consumption Value Forecast by Type (2024-2029)
Table 67. Global Chronic Cough Consumption Value by Application (2018-2023)
Table 68. Global Chronic Cough Consumption Value Forecast by Application (2024-2029)
Table 69. North America Chronic Cough Consumption Value by Type (2018-2023) & (USD Million)
Table 70. North America Chronic Cough Consumption Value by Type (2024-2029) & (USD Million)
Table 71. North America Chronic Cough Consumption Value by Application (2018-2023) & (USD Million)
Table 72. North America Chronic Cough Consumption Value by Application (2024-2029) & (USD Million)
Table 73. North America Chronic Cough Consumption Value by Country (2018-2023) & (USD Million)
Table 74. North America Chronic Cough Consumption Value by Country (2024-2029) & (USD Million)
Table 75. Europe Chronic Cough Consumption Value by Type (2018-2023) & (USD Million)
Table 76. Europe Chronic Cough Consumption Value by Type (2024-2029) & (USD Million)
Table 77. Europe Chronic Cough Consumption Value by Application (2018-2023) & (USD Million)
Table 78. Europe Chronic Cough Consumption Value by Application (2024-2029) & (USD Million)
Table 79. Europe Chronic Cough Consumption Value by Country (2018-2023) & (USD Million)
Table 80. Europe Chronic Cough Consumption Value by Country (2024-2029) & (USD Million)
Table 81. Asia-Pacific Chronic Cough Consumption Value by Type (2018-2023) & (USD Million)
Table 82. Asia-Pacific Chronic Cough Consumption Value by Type (2024-2029) & (USD Million)
Table 83. Asia-Pacific Chronic Cough Consumption Value by Application (2018-2023) & (USD Million)
Table 84. Asia-Pacific Chronic Cough Consumption Value by Application (2024-2029) & (USD Million)
Table 85. Asia-Pacific Chronic Cough Consumption Value by Region (2018-2023) & (USD Million)
Table 86. Asia-Pacific Chronic Cough Consumption Value by Region (2024-2029) & (USD Million)
Table 87. South America Chronic Cough Consumption Value by Type (2018-2023) & (USD Million)
Table 88. South America Chronic Cough Consumption Value by Type (2024-2029) & (USD Million)
Table 89. South America Chronic Cough Consumption Value by Application (2018-2023) & (USD Million)
Table 90. South America Chronic Cough Consumption Value by Application (2024-2029) & (USD Million)
Table 91. South America Chronic Cough Consumption Value by Country (2018-2023) & (USD Million)
Table 92. South America Chronic Cough Consumption Value by Country (2024-2029) & (USD Million)
Table 93. Middle East & Africa Chronic Cough Consumption Value by Type (2018-2023) & (USD Million)
Table 94. Middle East & Africa Chronic Cough Consumption Value by Type (2024-2029) & (USD Million)
Table 95. Middle East & Africa Chronic Cough Consumption Value by Application (2018-2023) & (USD Million)
Table 96. Middle East & Africa Chronic Cough Consumption Value by Application (2024-2029) & (USD Million)
Table 97. Middle East & Africa Chronic Cough Consumption Value by Country (2018-2023) & (USD Million)
Table 98. Middle East & Africa Chronic Cough Consumption Value by Country (2024-2029) & (USD Million)
Table 99. Chronic Cough Raw Material
Table 100. Key Suppliers of Chronic Cough Raw Materials
List of Figures
Figure 1. Chronic Cough Picture
Figure 2. Global Chronic Cough Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Chronic Cough Consumption Value Market Share by Type in 2022
Figure 4. Oral
Figure 5. Injections
Figure 6. Nasal
Figure 7. Others
Figure 8. Global Chronic Cough Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 9. Chronic Cough Consumption Value Market Share by Application in 2022
Figure 10. HospitalPharmacy Picture
Figure 11. OnlinePharmacy Picture
Figure 12. RetailPharmacy Picture
Figure 13. Global Chronic Cough Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global Chronic Cough Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Market Chronic Cough Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 16. Global Chronic Cough Consumption Value Market Share by Region (2018-2029)
Figure 17. Global Chronic Cough Consumption Value Market Share by Region in 2022
Figure 18. North America Chronic Cough Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Chronic Cough Consumption Value (2018-2029) & (USD Million)
Figure 20. Asia-Pacific Chronic Cough Consumption Value (2018-2029) & (USD Million)
Figure 21. South America Chronic Cough Consumption Value (2018-2029) & (USD Million)
Figure 22. Middle East and Africa Chronic Cough Consumption Value (2018-2029) & (USD Million)
Figure 23. Global Chronic Cough Revenue Share by Players in 2022
Figure 24. Chronic Cough Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 25. Global Top 3 Players Chronic Cough Market Share in 2022
Figure 26. Global Top 6 Players Chronic Cough Market Share in 2022
Figure 27. Global Chronic Cough Consumption Value Share by Type (2018-2023)
Figure 28. Global Chronic Cough Market Share Forecast by Type (2024-2029)
Figure 29. Global Chronic Cough Consumption Value Share by Application (2018-2023)
Figure 30. Global Chronic Cough Market Share Forecast by Application (2024-2029)
Figure 31. North America Chronic Cough Consumption Value Market Share by Type (2018-2029)
Figure 32. North America Chronic Cough Consumption Value Market Share by Application (2018-2029)
Figure 33. North America Chronic Cough Consumption Value Market Share by Country (2018-2029)
Figure 34. United States Chronic Cough Consumption Value (2018-2029) & (USD Million)
Figure 35. Canada Chronic Cough Consumption Value (2018-2029) & (USD Million)
Figure 36. Mexico Chronic Cough Consumption Value (2018-2029) & (USD Million)
Figure 37. Europe Chronic Cough Consumption Value Market Share by Type (2018-2029)
Figure 38. Europe Chronic Cough Consumption Value Market Share by Application (2018-2029)
Figure 39. Europe Chronic Cough Consumption Value Market Share by Country (2018-2029)
Figure 40. Germany Chronic Cough Consumption Value (2018-2029) & (USD Million)
Figure 41. France Chronic Cough Consumption Value (2018-2029) & (USD Million)
Figure 42. United Kingdom Chronic Cough Consumption Value (2018-2029) & (USD Million)
Figure 43. Russia Chronic Cough Consumption Value (2018-2029) & (USD Million)
Figure 44. Italy Chronic Cough Consumption Value (2018-2029) & (USD Million)
Figure 45. Asia-Pacific Chronic Cough Consumption Value Market Share by Type (2018-2029)
Figure 46. Asia-Pacific Chronic Cough Consumption Value Market Share by Application (2018-2029)
Figure 47. Asia-Pacific Chronic Cough Consumption Value Market Share by Region (2018-2029)
Figure 48. China Chronic Cough Consumption Value (2018-2029) & (USD Million)
Figure 49. Japan Chronic Cough Consumption Value (2018-2029) & (USD Million)
Figure 50. South Korea Chronic Cough Consumption Value (2018-2029) & (USD Million)
Figure 51. India Chronic Cough Consumption Value (2018-2029) & (USD Million)
Figure 52. Southeast Asia Chronic Cough Consumption Value (2018-2029) & (USD Million)
Figure 53. Australia Chronic Cough Consumption Value (2018-2029) & (USD Million)
Figure 54. South America Chronic Cough Consumption Value Market Share by Type (2018-2029)
Figure 55. South America Chronic Cough Consumption Value Market Share by Application (2018-2029)
Figure 56. South America Chronic Cough Consumption Value Market Share by Country (2018-2029)
Figure 57. Brazil Chronic Cough Consumption Value (2018-2029) & (USD Million)
Figure 58. Argentina Chronic Cough Consumption Value (2018-2029) & (USD Million)
Figure 59. Middle East and Africa Chronic Cough Consumption Value Market Share by Type (2018-2029)
Figure 60. Middle East and Africa Chronic Cough Consumption Value Market Share by Application (2018-2029)
Figure 61. Middle East and Africa Chronic Cough Consumption Value Market Share by Country (2018-2029)
Figure 62. Turkey Chronic Cough Consumption Value (2018-2029) & (USD Million)
Figure 63. Saudi Arabia Chronic Cough Consumption Value (2018-2029) & (USD Million)
Figure 64. UAE Chronic Cough Consumption Value (2018-2029) & (USD Million)
Figure 65. Chronic Cough Market Drivers
Figure 66. Chronic Cough Market Restraints
Figure 67. Chronic Cough Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Manufacturing Cost Structure Analysis of Chronic Cough in 2022
Figure 70. Manufacturing Process Analysis of Chronic Cough
Figure 71. Chronic Cough Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Novartis AG
Teva Pharmaceutical Industries Ltd
GlaxoSmithKline
Bayer AG
Mylan N.V.
Amneal Pharmaceuticals, Inc.
Cipla Inc.
Reckitt Benckiser Group
Sun Pharmaceutical Industries Ltd
Aurobindo Pharma Ltd
jiaGou

Add To Cart

gouMai

Buy Now